All News

Xtant™ Medical Announces First Surgical Case of Atrix-C™ Cervical Allograft Interbody Spacer

BELGRADE, Mont., Dec. 09, 2015 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the first surgical case of the Atrix-C Cervical Allograft Interbody Spacer. This

Interventional Spine Announces the First U.S. Implantation of its 3rd Generation Opticage Expandable Fusion Device at George Washington University by Dr. Warren Yu

IRVINE, Calif., Dec. 9, 2015 /PRNewswire/ — Interventional Spine today announced the first U.S. implantation of its 3rd Generation Opticage Expandable Interbody Fusion device. The next generation system is an enhanced version of the original Opticage system that was introduced in 2012. The

Anika Therapeutics Announces Decision to Proceed with CINGAL® Premarket Review Through FDA’s Center for Drug Evaluation and Research

BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced that the U.S. Food & Drug Administration’s (FDA) Office of Combination Products has assigned CINGAL® to

5 recent orthopedic, spine device company mergers & acquisitions

By Mary Rechtoris Here are five recent mergers and acquisitions that took place among spine and orthopedic companies. Cytos Biotechnology and Kuros Biosurgery merged. The merger will act as an exchange of Kuros shares for new Cytos shares, subject to shareholder approval

Emergency Physician Partners model keeps doctors in driver’s seat

By Richard Cowart Twenty years ago, the rage in Nashville was Physician Practice Management Companies (PPMCs).  Nashville-based Phycor was the gold standard, and Tennessee was home to a PPMC in virtually every specialty.  Examples included Women’s Health Partners (OB), Ortho

Population health on a budget: How one orthopedic surgeon succeeded in Chicago’s most impoverished neighborhoods

Daniel Ivankovich, MD, is one of a kind. For years, his physician colleagues thought he was crazy for establishing his practice among the most impoverished Chicago neighborhoods and treating almost exclusively Medicaid patients. He made house calls and…

BLOG: Does position of femoral attachment influence outcome after MPFL reconstruction?

In a paper we recently published, we observed that a non-anatomic femoral attachment in medial patellofemoral ligament reconstructive surgery does not always lead to a poor outcome. In fact, many patients with non-anatomic medial patellofemoral ligamen…

CollPlant Reports Positive Interim Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy

CollPlant Ltd. (TASE:CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, today announced positive interim clinical trial results for Vergenix™STR, intended for the treatment of tendinopathy. The objective of the Company’s prospective, open label,

X-Bolt to invest €1m in hip fracture clinical trials at Oxford University

By John Kennedy Dublin med tech firm X-Bolt Orthopedics is to spend €1m on a clinical trial of its hip fracture medical device at Oxford University. The 1,000-patient trial follows a successful clinical trial of 100 patients that showed a

New Research: Combining Adult Stem Cells with Hormone May Speed Bone Fracture Healing

LOS ANGELES (Dec. 8, 2015) ─ A combination of adult stem cells and parathyroid hormone significantly increased new bone formation in laboratory animals and may speed the healing process for human bone fractures caused by osteoporosis, a new study shows.

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1